PH20849A - Crystalline cephalexin bydrochloride monohydrate - Google Patents

Crystalline cephalexin bydrochloride monohydrate

Info

Publication number
PH20849A
PH20849A PH31493A PH31493A PH20849A PH 20849 A PH20849 A PH 20849A PH 31493 A PH31493 A PH 31493A PH 31493 A PH31493 A PH 31493A PH 20849 A PH20849 A PH 20849A
Authority
PH
Philippines
Prior art keywords
bydrochloride
monohydrate
crystalline cephalexin
cephalexin
crystalline
Prior art date
Application number
PH31493A
Other languages
English (en)
Inventor
Engel Gary Lowell
Indelicato Joseph Michel
Rose Harry Albert
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH20849A publication Critical patent/PH20849A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH31493A 1983-12-01 1984-11-27 Crystalline cephalexin bydrochloride monohydrate PH20849A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/556,887 US4600773A (en) 1983-12-01 1983-12-01 Crystalline cephalexin hydrochloride monohydrate

Publications (1)

Publication Number Publication Date
PH20849A true PH20849A (en) 1987-05-08

Family

ID=24223233

Family Applications (1)

Application Number Title Priority Date Filing Date
PH31493A PH20849A (en) 1983-12-01 1984-11-27 Crystalline cephalexin bydrochloride monohydrate

Country Status (46)

Country Link
US (1) US4600773A (ko)
EP (1) EP0143658B1 (ko)
JP (1) JPS60132990A (ko)
KR (1) KR870000527B1 (ko)
AT (1) AT390616B (ko)
AU (1) AU566080B2 (ko)
BE (1) BE901142A (ko)
BG (1) BG40966A3 (ko)
BR (1) BR8406037A (ko)
CH (1) CH661732A5 (ko)
CS (1) CS248725B2 (ko)
CY (1) CY1505A (ko)
DD (1) DD229410A5 (ko)
DE (1) DE3443065A1 (ko)
DK (1) DK158354C (ko)
ES (1) ES8602011A1 (ko)
FI (1) FI80274C (ko)
FR (1) FR2555990B1 (ko)
GB (1) GB2150566B (ko)
GR (1) GR81043B (ko)
GT (1) GT198400146A (ko)
HK (1) HK92089A (ko)
HU (1) HU192516B (ko)
IE (1) IE57886B1 (ko)
IL (1) IL73639A (ko)
IN (1) IN163078B (ko)
IT (1) IT1177329B (ko)
JO (1) JO1347B1 (ko)
LU (1) LU85650A1 (ko)
MA (1) MA20279A1 (ko)
MX (1) MX159670A (ko)
MY (1) MY102966A (ko)
NL (1) NL8403588A (ko)
NO (1) NO844711L (ko)
NZ (1) NZ210357A (ko)
OA (1) OA07876A (ko)
PH (1) PH20849A (ko)
PL (1) PL146014B1 (ko)
PT (1) PT79553B (ko)
SE (1) SE464026B (ko)
SG (1) SG59789G (ko)
SU (1) SU1251807A3 (ko)
YU (1) YU45680B (ko)
ZA (1) ZA849224B (ko)
ZM (1) ZM6384A1 (ko)
ZW (1) ZW19084A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2555989B1 (fr) * 1983-12-06 1987-02-20 Bristol Myers Sa Monohydrate de chlorocephadroxyle
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
US20040033262A1 (en) * 2002-08-19 2004-02-19 Orchid Health Care Sustained release pharmaceutical composition of a cephalosporin antibiotic

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507861A (en) * 1966-09-14 1970-04-21 Lilly Co Eli Certain 3-methyl-cephalosporin compounds
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
DE2317179C2 (de) * 1973-04-05 1982-11-25 Bristol-Myers Co., 10154 New York, N.Y. Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS50151890A (ko) * 1974-05-30 1975-12-06
CH642850A5 (it) * 1978-10-20 1984-05-15 Ausonia Farma Srl Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
DK158354C (da) 1990-10-01
NL8403588A (nl) 1985-07-01
GT198400146A (es) 1986-05-20
YU45680B (sh) 1992-07-20
SE8405954L (sv) 1985-06-02
CY1505A (en) 1990-08-03
BR8406037A (pt) 1985-08-27
FR2555990B1 (fr) 1986-12-26
AU566080B2 (en) 1987-10-08
KR870000527B1 (ko) 1987-03-14
DE3443065A1 (de) 1985-06-20
IN163078B (ko) 1988-08-06
IL73639A0 (en) 1985-02-28
DK561284D0 (da) 1984-11-27
GB2150566B (en) 1987-08-26
GR81043B (en) 1985-03-27
IE843033L (en) 1985-06-01
JPS60132990A (ja) 1985-07-16
HU192516B (en) 1987-06-29
PL250593A1 (en) 1985-07-30
SG59789G (en) 1989-12-29
NO844711L (no) 1985-06-03
ES538019A0 (es) 1985-11-01
FI80274C (fi) 1990-05-10
FI844631L (fi) 1985-06-02
IT8423746A1 (it) 1986-05-27
NZ210357A (en) 1988-05-30
ZM6384A1 (en) 1985-07-22
BE901142A (fr) 1985-05-28
MX159670A (es) 1989-08-02
IT1177329B (it) 1987-08-26
SE8405954D0 (sv) 1984-11-26
JO1347B1 (en) 1986-11-30
CS248725B2 (en) 1987-02-12
OA07876A (fr) 1986-11-20
MA20279A1 (fr) 1985-07-01
ZW19084A1 (en) 1985-06-12
DD229410A5 (de) 1985-11-06
MY102966A (en) 1993-03-31
DK158354B (da) 1990-05-07
PL146014B1 (en) 1988-12-31
FR2555990A1 (fr) 1985-06-07
EP0143658B1 (en) 1989-03-22
DE3443065C2 (ko) 1989-03-23
ES8602011A1 (es) 1985-11-01
EP0143658A2 (en) 1985-06-05
PT79553A (en) 1984-12-01
AU3589784A (en) 1985-06-06
KR850004765A (ko) 1985-07-27
PT79553B (en) 1986-12-15
YU199684A (en) 1987-02-28
SU1251807A3 (ru) 1986-08-15
EP0143658A3 (en) 1986-02-12
HK92089A (en) 1989-11-24
IE57886B1 (en) 1993-05-05
IL73639A (en) 1988-06-30
CH661732A5 (de) 1987-08-14
HUT35685A (en) 1985-07-29
AT390616B (de) 1990-06-11
JPH0548234B2 (ko) 1993-07-20
IT8423746A0 (it) 1984-11-27
US4600773A (en) 1986-07-15
GB2150566A (en) 1985-07-03
SE464026B (sv) 1991-02-25
LU85650A1 (fr) 1985-07-17
GB8430073D0 (en) 1985-01-09
FI844631A0 (fi) 1984-11-26
DK561284A (da) 1985-06-02
FI80274B (fi) 1990-01-31
ATA373284A (de) 1989-11-15
ZA849224B (en) 1986-07-30
BG40966A3 (en) 1987-03-14

Similar Documents

Publication Publication Date Title
GB8419190D0 (en) Cephem compounds
AU2920084A (en) Crystalline gallo-silicates
PH20849A (en) Crystalline cephalexin bydrochloride monohydrate
EP0146389A3 (en) Crystalline silicophosphoaluminate
GB8426338D0 (en) Cephem compounds
GB8309584D0 (en) Crystalline zincosilicate
EP0146390A3 (en) Crystalline silicophosphoaluminate
AU3688684A (en) Crystalline silicophosphoaluminate
AU2993184A (en) Crystalline polyphosphides
ZA849732B (en) Crystalline silicophosphoaluminate
AU568174B2 (en) Crystalline silicophosphoaluminate
PH18429A (en) Crystalline cephalosporin
GB2150931B (en) Chlorocefadroxil monohydrate
AU571040B2 (en) Crystalline silicophosphoaluminates
AU3689184A (en) Crystalline silicophosphoaluminate
GB8405879D0 (en) Cephalosporin c
ZA849730B (en) Crystalline silicophosphoaluminate
ZA849731B (en) Crystalline silicophosphoaluminate
GB8334554D0 (en) Cephalosporin compound
GB8311815D0 (en) Cephem compounds
GB8330472D0 (en) Cephem compounds
GB8629990D0 (en) Cephem compounds
GB8702639D0 (en) Cephem compounds
GB8329767D0 (en) Cephem compounds
GB8326333D0 (en) Cephem compounds